University of Texas at El Paso Jun 8 2026 A new study led by researchers at The University of Texas at El Paso found that use of weight loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use disorders. The study, led by UTEP School of Pharmacy researchers Tadesse Abegaz, Ph.D., and Gabriel Frietze, Ph.D., was published in Frontiers in Psychiatry . It looked at more than 142,000 cases of patients with type 2 diabetes or